Rgenta – Talk Bio

Actionable Insights Powered by AI

GSK Invests $546M in Rgenta’s RNA Modulation Technology for Cancer and Other Diseases

5 months ago talkbio0Tagged Cancer Therapeutic Procedure, Dosage Forms, Investments, Rgenta, RNA modulation, SmithKline Beecham

GSK, Rgenta, RNA modulation, cancer treatment, pharmaceutical investment